Literature DB >> 6982860

Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant.

N K Mak, Y H Zhang, G L Ada, G A Tannock.   

Abstract

The serum antibody response and four different cellular immune responses (cytotoxic T cells, delayed-type hypersensitivity T cells, natural killer cells, and cytotoxic macrophage levels) induced in CBA/H mice were measured at different times after intranasal inoculation of a cold-adapted (ca) variant of influenza A virus, influenza virus A/Ann Arbor/6/60-ca, or the parental virus, influenza virus A/Ann Arbor/6/60. At the highest dose of virus inoculated (5 log10 50% tissue culture infective doses), all four cellular responses reached high levels in the lungs of both groups of mice, and serum antibody titers were detected on day 20 after inoculation of either virus. However, whereas extensive replication of the parental virus occurred in the mouse lungs, very limited replication of the ca variant was observed. Macroscopically, infection with the parental virus caused gross lung damage, whereas such damage was almost absent in mice inoculated with the ca variant. Inoculation of 2 to 5 log10 50% tissue culture infective doses of the parental virus induced high cytotoxic T-cell responses, whereas only the highest dose of the ca variant caused a clearly significant cytotoxic T-cell response. As an inoculum of 5 log10 50% tissue culture infective doses of the ca variant caused a substantial primary immune response without appreciable lung damage, the avirulence of the ca variant may be primarily related to its limited ability to replicate productively in mouse lungs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982860      PMCID: PMC347722          DOI: 10.1128/iai.38.1.218-225.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Vaccination against influenza: a five-year study in the Post Office.

Authors:  J W Smith; R Pollard
Journal:  J Hyg (Lond)       Date:  1979-08

2.  Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.

Authors:  T W Hoskins; J R Davies; A J Smith; C L Miller; A Allchin
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

Review 3.  An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses.

Authors:  G L Ada; K N Leung; H Ertl
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Different functions of subsets of effector T cells in murine influenza virus infection.

Authors:  K N Leung; G L Ada
Journal:  Cell Immunol       Date:  1982-03-01       Impact factor: 4.868

5.  Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain.

Authors:  S B Spring; H F Maassab; A P Kendal; B R Murphy; R M Chanock
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent.

Authors:  M I Mahmud; H F Maassab; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

7.  Production of DTH in the mouse to influenza virus: comparison with conditions for stimulation of cytotoxic T cells.

Authors:  K N Leung; G L Ada
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

8.  A murine model for assessment of living attenuated influenza A vaccines.

Authors:  M C Wark; G A Tannock; M M Sutherland; L E Smith
Journal:  Aust J Exp Biol Med Sci       Date:  1980-12

9.  The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus.

Authors:  N K Mak; K N Leung; G L Ada
Journal:  Scand J Immunol       Date:  1982-06       Impact factor: 3.487

10.  Studies on the pathogenesis of influenzal pneumonitis; intranasal vs. intravenous infection of mice.

Authors:  R R WAGNER
Journal:  Yale J Biol Med       Date:  1956-06
View more
  12 in total

1.  Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.

Authors:  G A Tannock; J A Paul; R D Barry
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

2.  Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.

Authors:  G J Gorse; R B Belshe
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 3.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

4.  Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses.

Authors:  S J Tao; N K Mak; G L Ada
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.

Authors:  D J Morgan; N J Dimmock
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses.

Authors:  N K Mak; C Sweet; G L Ada; G A Tannock
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

Review 7.  New aspects of influenza viruses.

Authors:  M W Shaw; N H Arden; H F Maassab
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

8.  Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Authors:  Sarah A Kopecky-Bromberg; Kathryn A Fraser; Natalie Pica; Elena Carnero; Thomas M Moran; Richard W Franck; Moriya Tsuji; Peter Palese
Journal:  Vaccine       Date:  2009-04-23       Impact factor: 3.641

9.  Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.

Authors:  Grace L Chen; Elaine W Lamirande; Hong Jin; George Kemble; Kanta Subbarao
Journal:  Virology       Date:  2009-12-24       Impact factor: 3.616

10.  Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5.

Authors:  Gerald A Capraro; John B Johnson; Nancy D Kock; Griffith D Parks
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.